Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial

BACKGROUND: Several repurposed drugs such as hydroxychloroquine (HCQ) have been investigated for treatment of COVID-19, but none was confirmed to be efficacious. While in vitro studies have demonstrated antiviral properties of HCQ, data from clinical trials were conflicting regarding its benefit for...

Descripción completa

Detalles Bibliográficos
Autores principales: Byakika-Kibwika, Pauline, Sekaggya-Wiltshire, Christine, Semakula, Jerome Roy, Nakibuuka, Jane, Musaazi, Joseph, Kayima, James, Sendagire, Cornelius, Meya, David, Kirenga, Bruce, Nanzigu, Sarah, Kwizera, Arthur, Nakwagala, Fred, Kisuule, Ivan, Wayengera, Misaki, Mwebesa, Henry G., Kamya, Moses R., Bazeyo, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647506/
https://www.ncbi.nlm.nih.gov/pubmed/34872511
http://dx.doi.org/10.1186/s12879-021-06897-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647506/
https://www.ncbi.nlm.nih.gov/pubmed/34872511
http://dx.doi.org/10.1186/s12879-021-06897-9

Ejemplares similares